Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof
US6090789A · kind A · utility
10Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 1997 |
| Grant date | Jul 18, 2000 |
| Priority date | — |
| Expiry date | Nov 24, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/812
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a process for synthesizing a compound having the structure: ##STR1## wherein R is H, as well as related oligosaccharides useful as a vaccine for inducing antibodies to human breast cancer cells in an adjuvant therapy therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.